As of 2026-03-27, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 26.32 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.15 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 17449.7%.
The range of the Relative Valuation is 15.84 - 39.97 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.0x - 20.9x | 18.9x |
| Forward P/E multiples | 15.4x - 20.8x | 18.2x |
| Fair Price | 15.84 - 39.97 | 26.32 |
| Upside | 10459.3% - 26545.8% | 17449.7% |
| Date | P/E |
| 2026-03-24 | 0.16 |
| 2026-03-19 | 0.09 |
| 2026-03-17 | 0.01 |
| 2026-03-16 | 0.00 |
| 2026-03-09 | 0.37 |
| 2026-03-02 | 0.16 |
| 2026-02-27 | 0.16 |
| 2026-02-26 | 0.21 |
| 2026-02-19 | 0.21 |
| 2026-02-13 | 0.27 |
| 2026-02-12 | 0.27 |
| 2026-02-09 | 0.27 |
| 2026-02-06 | 0.27 |
| 2026-02-05 | 0.27 |
| 2026-02-03 | 0.27 |
| 2026-01-30 | 0.27 |
| 2026-01-27 | 0.38 |
| 2026-01-21 | 0.75 |
| 2026-01-16 | 0.54 |
| 2026-01-14 | 0.91 |
| 2026-01-13 | 0.37 |
| 2026-01-12 | 0.36 |
| 2026-01-08 | 0.41 |
| 2026-01-07 | 0.36 |
| 2026-01-05 | 0.36 |
| 2026-01-02 | 0.36 |
| 2025-12-31 | 0.75 |
| 2025-12-30 | 0.36 |
| 2025-12-29 | 0.36 |